港股異動 | 香港航天科技(1725.HK)跌近10% 預計年度由盈轉虧不超6000萬元
格隆匯3月14日丨香港航天科技(1725.HK)跌近10%,報14.5港元,總市值45億港元。香港航天科技公吿,公司預期於截至2021年12月31日止財政年度將錄得不多於人民幣6000萬元的估計淨虧損,而截至2020年12月31日止財政年度則錄得淨利潤約人民幣1730萬元。估計淨虧損主要由於2021財政年度內從事航天業務產生額外的行政開支,以及電子製造服務業務的毛利下降。2021財政年度內電子製造服務業務的毛利下降主要由於原材料成本增加。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.